News
Laboratory Research Technician – Cell Culture & Immunology
As a Laboratory Research Technician, you will support the mission-critical daily research activities that keep our TCR-T cell programs moving forward.
Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
Pan Cancer T has secured EUR 10 million to move its TCR T cell therapy for triple negative breast cancer into first-in-human trials
Pan Cancer T announces that Dr. Helen Tayton-Martin has joined its board as an independent director
Dr. Helen Tayton-Martin joins our board, bringing decades of leadership in TCR-T cell therapy and biotech growth.
Pan Cancer T’s potential recognised at MEET2WIN with two awards
Pan Cancer T’s strong investment potential was highlighted at MEET2WIN with two awards, giving CEO Rachel Abbott a platform to present in depth and receive direct feedback from leading European oncology experts and top pharma companies.
Extended Partnership with NecstGen
Pan Cancer T, a preclinical biotech focussing on the development of next-generation TCR-T treatments, has extended its collaboration with Leiden based NecstGen to include the development and clinical manufacturing of retroviral vectors. The parties have agreed to...
4.25 Million in Seed Extension Round
Pan Cancer T B.V., a pioneering biotech start-up developing next-generation T cell therapies for solid cancer treatment, has successfully closed a €4.25 million Seed Extension round.
Pan Cancer T are EIT Health Catapult Finalists
On 5th June, our CEO, Rachel Abbott, was pleased to represent Pan Cancer T in the EIT Health Catapult finals at the health.tech global summit in Munich.
Awarded the Seal of Excellence from the European Commission
Amongst a record number of applicants, Pan Cancer T’s EIC Accelerator proposal has been awarded the Seal of Excellence.
Selected as semi finalist of the EIT Health Catapult venture challenge
Pan Cancer T has been selected as semi finalist of the EIT Health Catapult venture challenge
Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer